Seroconversion after hepatitis B vaccination by intragluteal or upper arm injection
Steinmann, J.; Arnold, W.
Deutsche Medizinische Wochenschrift 110(38): 1472-1473
1985
ISSN/ISBN: 0012-0472 PMID: 4029001 Document Number: 261567
Document emailed within 1 workday
Related Documents
Ramesh, M.; Marwaha, R.K.; Chawla, Y.K.; Trehan, A. 2000: Seroconversion after hepatitis B vaccination in children receiving cancer chemotherapy Indian Pediatrics 37(8): 882-886Krairittichai, U.; Sethakarun, S. 2017: A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3 Journal of the Medical Association of Thailand 100(Suppl 1): S1-S7
Oliveira, S.A.N.; Hacker, M.A.; Oliveira, M.L.A.; Yoshida, C.F.T.; Telles, P.R.; Bastos, F.I. 2005: A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination Revista Panamericana de Salud Publica 18(4-5): 271-277
Tkachenko, L.I.; Maleev, V.V.; Putrenok, L.S. 2013: Evaluation of seroconversion after vaccination of medical staff against HBV infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 5: 69-74
Choudhury, D.S.; Nossik, N.N.; Bindu; Vijayan, P.; Raghavan, N.G.; Paul, S.S. 1973: Poliomyelitis vaccination of infants: preimmunization status and seroconversion Bulletin of the World Health Organization 48(2): 195-198
Jahani, M.R.; Kheirandish, P.; Hosseini, M.; Shirzad, H.; Seyedalinaghi, S.A.; Karami, N.; Valiollahi, P.; Mohraz, M.; McFarland, W. 2009: HIV seroconversion among injection drug users in detention, Tehran, Iran Aids 23(4): 538-540
Cozzi Lepri, A.; Phillips, A.N.; Pezzotti, P.; Mocroft, A.; Sabin, C.A.; Porter, K.; Rezza, G. 1998: Evaluating the effect of year of seroconversion on HIV progression in cohort studies. Italian Seroconversion Study Aids 12(11): 1353-1360
Čalkić, L.; Bajramović-Omeragić, L.; Husić-Selimović, A.; Aličković, I. 2017: Hbsag Seroconversion in the Treatment of Chronic Hepatitis B with Pegylated Interferon Lijecnicki Vjesnik 139(1-2): 29-32
Oguz, Y.; Doganci, L.; Vural, A. 2001: Seroconversion rates of two different doses of hepatitis B vaccine in Turkish haemodialysis patients Central European Journal of Public Health 9(1): 44-45
Lisowska, B. 1989: Seroconversion of hepatitis B markers in exposed health service workers after 1 year Przeglad Epidemiologiczny 43(3): 309-314
Chanchairujira, T.; Chantaphakul, N.; Thanwandee, T.; Ong-Ajyooth, L. 2006: Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients Journal of the Medical Association of Thailand 89(Suppl 2): S33-S40
Semba, R.D.; Munasir, Z.; Beeler, J.; Akib, A.; Muhilal; Audet, S.; Sommer, A. 1995: Reduced seroconversion to measles in infants given vitamin A with measles vaccination Lancet 345(8961): 1330-1332
Hashizume, K.; Fujiwara, A.; Watanabe, K.; Kamihara, M.; Iwasaki, S.; Yamagami, H. 2019: A Prospective Comparison of CT-Epidurogram Between Th1-Transforaminal Epidural Injection and Th1/2-Parasagittal Interlaminar Epidural Injection for Cervical Upper Limb Pain Pain Physician 22(2): 165-176
Aubourg, A.; d'Alteroche, L.; Senecal, D.; Gaudy, C.; Bacq, Y. 2007: Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation Gastroenterologie Clinique et Biologique 31(1): 97-99
Gregorek, H.; Dzierzanowska-Fangrat, K.; Woynarowski, M.; Jóźwiak, P.; Witkowska-Vogtt, E.; Wojda, U.; Syczewska, M.łg.; Socha, J.; Madalińiski, K. 2005: Persistence of hepatitis B virus in children after interferon-alpha therapy despite the seroconversion in HBsAg/anti-HBs system Przeglad Epidemiologiczny 59(3): 641-649
Garfein, R.S.; Golub, E.T.; Greenberg, A.E.; Hagan, H.; Hanson, D.L.; Hudson, S.M.; Kapadia, F.; Latka, M.H.; Ouellet, L.J.; Purcell, D.W.; Strathdee, S.A.; Thiede, H. 2007: A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users Aids 21(14): 1923-1932
Patrzałek, M.; Tarnowska, H. 1999: Changes in the epidemiological situation of hepatitis B in Kielce region, after introduction of vaccination of infants against hepatitis B Przeglad Epidemiologiczny 53(1-2): 181-185
Karatekin, G.; Kilinç, M.; Gulcan Öksuz, B.; Iğde, M. 2013: Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea Region of Turkey Journal of Infection in Developing Countries 7(12): 960-965
Li, R-cheng.; Yang, J-ye.; Gong, J.; Li, Y-ping.; Huang, Z-neng.; Fang, K-xiong.; Xu, Z-yi.; Liu, C-bai.; Zhao, K.; Zhuang, H. 2004: Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma Zhonghua Liu Xing Bing Xue Za Zhi 25(5): 385-387
Fredericks, T.; Kwan, K.; Mak, D. 2010: Hepatitis a and B vaccination--the rate of uptake and course completion in patients with hepatitis C Australian Family Physician 39(10): 784-786